Examining the impact of fish oil on pruritus in individuals undergoing hemodialysis
Not Applicable
- Conditions
- Chronic kidney disease, stage 5, on dialysis.Chronic kidney disease, stage 5N18.5
- Registration Number
- IRCT20211206053309N1
- Lead Sponsor
- Jeeroft University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Individuals must be over 18 years of age
Have experienced itching within the last two weeks without any identifiable cause such as a skin condition
Have undergone hemodialysis treatment at least three times a week for the past six months
Exclusion Criteria
Have any hearing or speech impairments
Treating itchiness with medication.
Have any open wounds, deep vein thrombosis, epilepsy, bleeding disorders, paraplegia, cellulitis, or a pacemaker
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pruritus. Timepoint: Before the intervention, at the end of two weeks following the intervention, before using the placebo, and after two weeks of using the placebo. Method of measurement: Yosipovitch Questionnaire.
- Secondary Outcome Measures
Name Time Method Adverse effects of treatment (Skin Allergy). Timepoint: days of 1, 3 ,7 after treatment. Method of measurement: Assessment and physical examination, question from patient.